microdosing glp 1 alzheimer's GLP-1 Microdosing, Brain Health & Prevention Weight Loss Drugs May Protect

In a pre- and postnatal development study in pregnant Sprague Dawley rats, SNAC was administered orally at 1,000 mg/kg/day (exposure levels were not measured) on Gestation Day 7 through Lactation Day 20

Beyond their well-known weight loss effects, studies emerging this month position GLP-1s as potential healthcare game-changers, showing promise in reducing orthopedic surgery rates, addiction, cancer risks, and even the pace of metabolic aging

Self-insured employers are bigger companies with more resources that hire an insurer like Blue Cross to administer an insurance plan, but the employer assumes the risk of claims exceeding premiums

IGF-1 LR3 supports the kind of change that training alone can't always deliver